Trimethylammonium

Trimethylammonium

SCHEMBL17819099

CN(C)C.CNC.OB(O)O.OB(O)O

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Boric Acid SCHEMBL431359 0.85
Trimethylammonium SCHEMBL1411855 0.85
Boric Acid SCHEMBL8755210 0.85 LMNA (0.50) LMNATSHRTDP1
Boric Acid SCHEMBL7952456 0.85 LMNA (0.50) LMNATSHRTDP1
Boric Acid SCHEMBL8754803 0.85 LMNA (0.50) LMNATSHRTDP1
Boric Acid SCHEMBL8755195 0.85 LMNA (0.50) LMNATSHRTDP1
Trimethylammonium SCHEMBL7953164 0.85 LMNA (0.50) LMNATSHRTDP1
Boric Acid SCHEMBL717521 0.85 LMNA (0.50) LMNATSHRTDP1
Boric Acid SCHEMBL10338315 0.85 LMNA (0.50) LMNATSHRTDP1
Boric Acid SCHEMBL28793742 0.80 LMNA (0.44) LMNATSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10471126-B2 Pegylated interleukin-10 MERCK SHARP & DOHME LTD (US) 2019-11-12 US disclosed
US-20180250363-A1 Pegylated Interleukin-10 SCHERING CORPORATION 2018-09-06 US disclosed
US-9925245-B2 Pegylated interleukin-10 MERCK SHARP & DOHME CORP. (US) 2018-03-27 US disclosed
US-20160166647-A1 Pegylated Interleukin-10 MERCK SHARP & DOHME CORP. 2016-06-16 US disclosed